The profitability of Belite Bio, Inc over the past 6 years
Chart Belite Bio, Inc: operating income, net income, fiscal 2020–2025 Open the chart →Belite Bio, Inc reported a net loss of $77.61M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $84.21M. It reported a loss in all 6 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$84.21M | -$77.61M |
| 2024ended Dec 31, 2024 | -$40M | -$36.14M |
| 2023ended Dec 31, 2023 | -$31.67M | -$31.63M |
| 2022ended Dec 31, 2022 | -$12.82M | -$12.65M |
| 2021ended Dec 31, 2021 | -$9.8M | -$9.67M |
| 2020ended Dec 31, 2020 | -$5.74M | -$5.75M |
Fiscal years as Belite Bio, Inc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Belite Bio, Inc
- The cash flow of Belite Bio, Inc
- The debt of Belite Bio, Inc
- All of Belite Bio, Inc's financials, charted
Companies of a similar size
- KBRKBR, Inc.
- OPCHOPTION CARE HEALTH, INC.
- OBDCBLUE OWL CAPITAL CORP
- PORPORTLAND GENERAL ELECTRIC COMPANY
- MAINMain Street Capital Corporation
Not investment advice. This page shows what Belite Bio, Inc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.